CME vs. S&P Global: Which Financial Stock Is a Better Buy for 2027?

Impact · against what's priced in

The article provides no new catalysts for CME or SPGI, as the financial metrics and partnership details mentioned are already reflected in current valuations. The reported revenue and margin strengths for CME merely confirm the high-margin 'toll-bridge' profile the market already assumes.

CME+0.00

Already priced in

The price assumes

The current 64.3% free-cash-flow margin and 86.1% gross margin sustained indefinitely